67Cu-2IT-BAT-Lym-1

N/A

Report date: 2025/11/18 17:45:23

Base Information

Drug Name67Cu-2IT-BAT-Lym-1

Drug Alias Name67Cu-2IT-BAT-Lym-1

ClassificationRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Copper > 67Cu +[4]

Mechanisms of ActionAnti-CD74

TargetsHLA-DR antigens-associated invariant chain

Therapy Area/IndicationsLymphoma, Non-Hodgkin

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of California

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of California

Active IndicationsN/A

Inactive IndicationsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A